Division of Pediatrics, Children's Cancer Hospital of The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pediatr Blood Cancer. 2013 Jan;60(1):12-7. doi: 10.1002/pbc.24293. Epub 2012 Sep 21.
Peritoneal sarcomatosis (PSC) is defined as peritoneal involvement of multiple sarcomatous tumors. Desmoplastic small round cell tumors (DSRCT) and rhabdomyosarcomas are the most common pediatric PSC cases. PSC has been treated with chemotherapy and mainly palliative surgery, but long-term outcome has been poor. New imaging technologies have improved the evaluation of disease extent and patterns of peritoneal dissemination, and cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC) is being evaluated as a treatment option to prolong remission in pediatric patients. We will review the clinical characteristics, potential biologic mechanisms, radiographic characteristics, and potential therapies for pediatric PSC patients.
腹膜肉瘤病(PSC)定义为多个肉瘤样肿瘤累及腹膜。促结缔组织增生性小圆细胞肿瘤(DSRCT)和横纹肌肉瘤是最常见的儿科 PSC 病例。PSC 采用化疗和主要姑息性手术治疗,但长期预后较差。新的成像技术提高了对疾病范围和腹膜播散模式的评估,细胞减灭术加腹腔热灌注化疗(HIPEC)正在被评估为一种治疗选择,以延长儿科患者的缓解期。我们将回顾儿科 PSC 患者的临床特征、潜在生物学机制、影像学特征和潜在治疗方法。